by Anna Tan | Nov 14, 2018 | Featured Posts
Moving Forward with Proper PGx Expectations 2,5 Pharmacogenomic (PGx) testing and PGx-based treatments may be all the rage in precision medicine today, but more genetic and pharmacology experts – especially in the areas of cardiology, pain management, and psychiatry –...
by Anna Tan | Nov 8, 2018 | Pharmacy
Moving Forward with Remote Support The intimidating costs behind patient-centered healthcare reform can be mitigated with the added revenue and reduced labor costs of establishing remote pharmacy models (RPMs). These highly efficient sites not only give operational...
by Anna Tan | Nov 1, 2018 | Pharmacy
Moving Forward with New Provisions The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), signed on October 24, 2018, addresses the opioid crisis by reducing supply and access while...
by Anna Tan | Oct 17, 2018 | Press & Media
For Immediate Release: October 17, 2018 — Phoenix, AZ STATEMENT: Web-based point-of-care solutions provider, PEPID, LLC, released a new feature on their IV Compatibility Checker that adds an extra layer of assurance to, not only safe, but effective IV drug...
by Anna Tan | Oct 15, 2018 | Pharmacy, Primary Care
Getting a Bigger Slice of the P.I.E.: The Pharmacist’s Duties in Clinical Pharmacogenomics (PGx) Ninety percent of Americans live within 5 miles of a community pharmacy, with local patients averaging 35 drugstore visits annually. Compared to the average frequency of 4...
